Stimulating PBMCs from NSCLC patients with RLI showed that it systematically increased the expression of activating receptors NKp30, NKp44, CD107a, and intracellular TNF-α, indicating that RLI could rescue the functionality of NK cells in patients with NSCLC [30]. This evidence concerns the gene NCR2 and non-small cell lung carcinoma.